Platelet FcγRIIA in immunity and thrombosis: Adaptive immunothrombosis

Area of Science:

• Immunology
• Hematology
• Pathology

Background:

• Sepsis and autoimmune diseases cause significant morbidity and mortality.
• Platelets are increasingly recognized for their dual roles in host defense, immunity, and thrombosis.
• Platelets act as early responders to pathogens and antigens, influencing both innate and adaptive immunity.

Purpose of the Study:

• To review recent advancements in understanding the role of platelet FcγRIIA in human immunity and thrombosis.
• To highlight the involvement of FcγRIIA in specific conditions such as heparin-induced thrombocytopenia, systemic lupus erythematosus, and bacterial sepsis.
• To discuss the significance of human genetic diversity in platelet receptors and the application of humanized mouse models.

Main Methods:

• Review of current literature on platelet FcγRIIA function.
• Analysis of studies involving humanized mouse models.
• Examination of genetic variations in human platelet receptors.

Main Results:

• Platelet FcγRIIA mediates responses to immune complexes, impacting host defense and pathological thrombosis.
• The concept of adaptive immunothrombosis integrates the roles of IgG, Fc receptors, and platelets in response to microbes and autoantigens.
• FcγRIIA is implicated in the pathogenesis of heparin-induced thrombocytopenia, systemic lupus erythematosus, and bacterial sepsis.

Conclusions:

• Platelet FcγRIIA is a critical mediator in adaptive immunothrombosis, bridging immunity and thrombosis.
• Understanding FcγRIIA's role is vital for developing therapeutic strategies for sepsis, autoimmune diseases, and related thrombotic complications.
• Humanized mouse models and studies of human genetic diversity are essential for advancing this field.